Supplemental material
Journal of Medical Economics
Volume 24, 2021 - Issue 1
Open access
3,450
Views
3
CrossRef citations to date
0
Altmetric
Oncology
Budget impact of tepotinib in the treatment of adult patients with metastatic non-small cell lung cancer harboring METex14 skipping alterations in the United States
Matthew Stargardtera Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA
, Ali McBrideb The University of Arizona College of Pharmacy – Tucson, Tucson, AZ, USA
https://orcid.org/0000-0002-9430-4675
Jon Toshc Evidera, Evidence Synthesis, Modeling, & Communication, London, UK
https://orcid.org/0000-0002-8288-4270
Rameet Sachdeva Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA
, Mo Yangd EMD Serono, Rockland, MA, USA
, Apoorva Ambavanea Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA
, Madhav Mittala Evidera, Evidence Synthesis, Modeling, & Communication, Bethesda, MD, USA
, Helene Vioixe Merck KGaA, Darmstadt, Germany
& Frank Xiaoqing Liud EMD Serono, Rockland, MA, USACorrespondence[email protected]
show all
Pages 816-827
|
Received 25 May 2021, Accepted 09 Jun 2021, Published online: 05 Jul 2021
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.